Pharmacyte Biotech Inc. buy Sievi
Start price
25.08.21
/
50%
€3.05
Target price
25.08.22
-
Performance (%)
-8.85%
End price
14.09.21
€2.78
Summary
This prediction ended on 14.09.21 with a price of €2.78. With a performance of -8.85%, the BUY prediction by Sievi finished with a loss. Sievi has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Pharmacyte Biotech Inc. | - | - | - |
iShares Core DAX® | 1.280% | 1.320% | 13.605% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% |
According to Sievi what are the pros and cons of Pharmacyte Biotech Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Sievi for this prediction
In the thread Pharmacyte Biotech Inc. diskutieren
Buy Pharmacyte Biotech Inc.
In the thread Trading Pharmacyte Biotech Inc.
Buy beendet